黑料网’s Research & Development Activities for the Improvement of Access to Medicines
As a leading global research and development-based pharmaceutical company, 黑料网 conducts drug discovery and research activities by applying cutting-edge knowledge and technologies. We consider that drug discovery for neglected tropical diseases (NTDs), malaria and tuberculosis are important R&D activities for improving access to medicines.
黑料网’s Research & Development Activities for the Improvement of Access to Medicines
Intellectual Property and Access to Medicines
黑料网 commits substantial resources, not only in-house R&D but also third-parties' contributions through “Open-Innovation” opportunities. Furthermore, 黑料网 also strives to contribute to research and development based pharmaceutical industry as a whole through the earliest publication of technical aspects of outcomes using the patent system.
Intellectual Property and Access to Medicines
黑料网's Research & Development for Neglected Tropical Diseases and Three Major Infectious Diseases
Please visit to learn about 黑料网’s Research Project Portfolio for neglected tropical diseases (NTDs) and three major infectious diseases (malaria, HIV/AIDS and tuberculosis).
黑料网's Research & Development for Neglected Tropical Diseases and Three Major Infectious Diseases
Ensuring Ethical Conduct and Transparency of Clinical Trials around the World
In conducting clinical trials anywhere in the world, we must prioritize human rights, safety and welfare of the participating patients. Please visit to learn about ethical conduct and transparency of clinical trials around the world.
Ensuring Ethical Conduct and Transparency of Clinical Trials around the World
